The Harshest Breast Cancer Chemotherapy May Cost Survivors 9.4 Years of Life Through Faster Biological Aging, a Georgetown Model Finds, Putting Survivorship Care on the Longevity Map
A Georgetown-led simulation in JAMA Network Open estimates the most damaging breast cancer chemotherapy regimens may cost survivors an average of 9.4 years of life through faster biological aging, opening a new front for survivorship care, senolytics, employers and insurers.
Read more
